SCHEMBL23825840

SCHEMBL23825840

CC(C)(C)OC(=O)N[C@H]1CC[C@H](Nc2cc(C(=O)O)ccc2Br)CC1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KDM1A O60341 1/20 0.46
▸ MAOB P27338 1/20 0.46
▸ HCAR3 P49019 3/20 0.43
▸ BTK Q06187 6/20 0.40
▸ KMT2A Q03164 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ DRD2 P14416 2/20 0.39
▸ NAMPT P43490 1/20 0.39
▸ KCNA3 P22001 1/20 0.39
▸ EPHX2 P34913 1/20 0.38
▸ CKS1B P61024 1/20 0.38
▸ SKP1 P63208 1/20 0.38
▸ SKP2 Q13309 1/20 0.38
▸ NFKB1 P19838 1/20 0.38
▸ NFKB2 Q00653 1/20 0.38
▸ RELA Q04206 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ HDAC8 Q9BY41 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23825838 1.00 KDM1A (0.46) KDM1AMAOBHCAR3BTKKMT2A
SCHEMBL29366142 0.88 MAPK14 (0.42) KDM1AMAOBBTKKMT2AL3MBTL1
SCHEMBL23825779 0.86 DRD2 (0.42) KDM1AMAOBKMT2AL3MBTL1DRD2
SCHEMBL23826085 0.86 ALOX15 (0.49) KDM1AMAOBBTKDRD2EPHX2
SCHEMBL23826087 0.86 ALOX15 (0.49) KDM1AMAOBBTKDRD2EPHX2
SCHEMBL23826504 0.85 KDM1A (0.41) KDM1AMAOBBTKKMT2AL3MBTL1
SCHEMBL2428995 0.83 DRD2 (0.44) KDM1AMAOBHCAR3BTKKMT2A
SCHEMBL2428992 0.83 DRD2 (0.44) KDM1AMAOBHCAR3BTKKMT2A
SCHEMBL31336610 0.77 KDM1A (0.48) KDM1AMAOBBTKKMT2AL3MBTL1
SCHEMBL25042395 0.76 KDM1A (0.45) KDM1AMAOBBTKKMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220024921-A1 1,3,4-OXADIAZOLONE COMPOUND AND PHARMACEUTICAL NIPPON SHINYAKU CO., LTD. (JP) 2022-01-27 — — US disclosed
EP-3882239-A1 1,3,4-OXADIAZOLONE COMPOUND AND MEDICINE Nippon Shinyaku Co., Ltd. (JP) 2021-09-22 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220024921-A1 1,3,4-OXADIAZOLONE COMPOUND AND PHARMACEUTICAL PIM1, PIM3, PIM2 KDM1A 334/4885MAOB 2103/4885HCAR3 3933/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback